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Abstract
The domestic dog (Canis familiaris) segregates more naturally-occurring diseases and phenotypic variation than any other
species and has become established as an unparalled model with which to study the genetics of inherited traits. We used a
genome-wide association study (GWAS) and targeted resequencing of DNA from just five dogs to simultaneously map and
identify mutations for two distinct inherited disorders that both affect a single breed, the Cavalier King Charles Spaniel. We
investigated episodic falling (EF), a paroxysmal exertion-induced dyskinesia, alongside the phenotypically distinct condition
congenital keratoconjunctivitis sicca and ichthyosiform dermatosis (CKCSID), commonly known as dry eye curly coat
syndrome. EF is characterised by episodes of exercise-induced muscular hypertonicity and abnormal posturing, usually
occurring after exercise or periods of excitement. CKCSID is a congenital disorder that manifests as a rough coat present at
birth, with keratoconjunctivitis sicca apparent on eyelid opening at 10–14 days, followed by hyperkeratinisation of footpads
and distortion of nails that develops over the next few months. We undertook a GWAS with 31 EF cases, 23 CKCSID cases,
and a common set of 38 controls and identified statistically associated signals for EF and CKCSID on chromosome 7 (Praw
1.9610
214;P genome=1.0610
25) and chromosome 13 (Praw 1.2610
217;P genome=1.0610
25), respectively. We resequenced
both the EF and CKCSID disease-associated regions in just five dogs and identified a 15,724 bp deletion spanning three
exons of BCAN associated with EF and a single base-pair exonic deletion in FAM83H associated with CKCSID. Neither BCAN or
FAM83H have been associated with equivalent disease phenotypes in any other species, thus demonstrating the ability to
use the domestic dog to study the genetic basis of more than one disease simultaneously in a single breed and to identify
multiple novel candidate genes in parallel.
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Introduction
The domestic dog is well documented as being an excellent
model for studying the genetics of both simple and complex traits
[1–3]. The purebred dog population comprises several hundred
distinct breeds that usually originate from small numbers of
founding individuals, with each breed representing an isolated and
relatively homogenous closed breeding population. Within breeds
there is strong selection for desired phenotypic and behavioural
characteristics, and dogs that possess these desired characteristics
are often bred with extensively. The resulting population structure
of individual breeds can result in the propagation of many
spontaneously occurring deleterious mutations within a breed and
these can exist at high frequencies, with the possibility of multiple
inherited disorders arising within a single breed. A large
proportion of these disorders show a Mendelian autosomal
recessive mode of inheritance. The Staffordshire Bull Terrier
and Labrador Retriever are two of the many examples of breeds
that are affected by at least two autosomal recessive disorders for
which the causal mutations have been identified; hereditary
cataract and the metabolic disorder L-2-hydroxyglutaric aciduria
in the Staffordshire Bull Terrier [4–5] and exercise induced
collapse and centronuclear myopathy in the Labrador Retriever
[6–7]. The high levels of homogeneity and long linkage
disequilibrium that are characteristic of the genomes of most
purebred dog breeds means that canine disease traits can be
mapped using much smaller numbers of cases and controls and far
more modest numbers of genetic markers than would be required
to map an equivalent disease in outbred human populations [8–9].
Episodic falling (EF) in the Cavalier King Charles Spaniel
(CKCS) was first reported in 1983, although the condition has
been recognised in the breed since at least the early 1960s [10]. EF
(also known within the breed as ‘‘sudden collapse’’, muscle
hypertonicity and hyperekplexia) is a paroxysmal exertion-induced
dyskinesia that is usually exercise, excitement or stress-induced and
is characterised by muscular hypertonicity and abnormal postur-
PLoS Genetics | www.plosgenetics.org 1 January 2012 | Volume 8 | Issue 1 | e1002462ing, with affected dogs appearing to demonstrate a temporary
inability to relax the affected limb and trunk muscles [10]. EF in
the CKCS has an age of onset of between three to seven months of
age, and affects both male and female dogs. Pedigree inspection
indicates that the disease has an autosomal recessive mode of
inheritance. The episodes are usually brief (less than five minutes)
and self-limiting, but the clinical signs between cases are variable,
with the length of an episode ranging from a few seconds to several
minutes. Episodes start with an increase in muscle tone, with
bunny-hopping movements [10] and/or presence of a ‘‘deer
stalker’’ gait [11]. The back may become arched and the head
held close to the ground leading to collapse, either to the side or
forwards. Legs may be held out in a rigid, extended fashion,
although in some cases the dog may return to the feet within
seconds of a collapse. In some of the most severe cases, forelegs or
hind legs become protracted until they are positioned over the top
of the dog’s head. Dogs appear to remain fully conscious during an
episode [10].
EF in the CKCS shares similarities to human disorders,
including idiopathic (familial and sporadic) paroxysmal exertion-
induced dyskinesia, hyperekplexia, Brody’s myopathy, and
myotonia. Paroxysmal dyskinesias comprise a spectrum of
conditions in human patients, all of which are characterised by
involuntary movements triggered by specific events. Paroxysmal
exertion-induced dyskinesia is a paroxysmal dyskinesia that is
induced by prolonged exercise of between 15 to 60 minutes
duration. Patients are variably affected, with episodes lasting from
minutes to a couple of hours. Episodes are usually restricted to
those muscle groups that have been exercised. The response to
treatment is poor, although some limited benefit has been
described using anticonvulsant medications [12]. Hyperekplexia
is a disease of exaggerated startle response and increased muscle
stiffness and rigidity which shows a particularly close resemblance
to EF in terms of the positive response to the drug clonazepam.
Clonazepam is thought to improve neurotransmission in gamma-
aminobutyric acid (GABA) inhibitory pathways [13]. The genes
GLRA1, GLRB, SLC6A5, and GPHN, which all encode proteins
involved in glycinergic neurotransmission, have been associated
with hyperekplexia in humans [14–17]. Brody’s myopathy is a
disease of exercised-induced muscle cramping with the inability to
relax muscles [18]. Mutations in the gene SERCA1 and ATP2A1
have been associated with Brody’s myopathy [19]. Myotonia is
described as a disease with delayed skeletal muscle relaxation after
sudden and often exaggerated contraction. Myotonia exists in both
autosomal recessive (Becker’s disease) and dominant forms
(Thomsen’s disease), and is caused by mutations in the CLCN1
gene [20–21]. Mutations in CLCN1 have been associated with
myotonia in Miniature Schnauzer and the Australian Cattle Dog
[22–23].
A distinct, congenital condition in the CKCS that affects the
skin, eyes and nails is the syndrome known as congenital
keratoconjunctivitis sicca and ichthyosiform dermatosis (CKCSID),
or more commonly referred to as ‘‘dry eye curly coat syndrome’’.
This condition, which was first reported in the scientific literature in
2006 [24], manifests at birth, with further clinical signs evident in
early life. Cases present with a congenitally abnormal (rough/curly)
coat, signs of keratoconjunctivitis sicca (KCS) from eyelid opening,
and are usually smaller than littermates. Reduced production of
aqueous tears and tear film qualitative abnormalities result in a
tacky mucoid or mucopurulent ocular discharge and ulceration of
thecorneainseverecases.Persistentscalealongthedorsalspineand
flanks with a harsh, frizzy and alopecic coat is evident in the first few
months of life, often causing the dog to scratch. Ventral abdominal
skin becomes hyperpigmented and hyperkeratinised in adulthood.
Footpads are hyperkeratinised from young adulthood with nail
growth abnormalities and intermittent sloughing, causing pain
and lameness. Affected dogs also tend to suffer increased dental
disease, some dogs requiring tooth extraction [24]. Examination
of the oral cavities of affected adult dogs revealed extensive tartar
formation with associated gingivitis, particularly of premolar and
molar teeth, in most cases. Frequently, single or multiple tooth
extraction had been undertaken if dogs had received dental
treatment under general anaesthesia. Tooth enamel, however,
was not grossly abnormal. Disease management is difficult, with
many owners opting to euthanize affected puppies on welfare
grounds. No other occurrences of combined KCS and ichthyo-
siform dermatosis have been reported in any other breeds in the
veterinary literature, although mutations associated with ichthy-
osis have been identified in the Norfolk Terrier and Jack Russell
Terrier [25–26]. Although no human conditions have been
described that closely resemble CKCSID, keratitis-ichthyosis-
deafness (KID) syndrome shares more than one similar clinical
sign, and is caused by mutations in the GJB2 gene encoding
connexin-26 [27–28]. A syndrome of woolly hair, premature
tooth loss, nail dystrophy, acral hyperkeratosis and facial
abnormalities has also been described in a human kindred, but
no ocular clinical signs were reported [29].
The aim of our investigation was to identify the mutations
associated with EF and CKCSID in the CKCS using a genome-
wide association study (GWAS) mapping approach, followed by
targeted resequencing to identify the causal variant underlying the
association signal for each disease. We sought to capitalise on the
fact that both conditions affect the same breed by using a common
set of controls for both the EF and CKCSID association studies
and a minimal number of dogs for resequencing and mutation
identification.
Results
We conducted GWAS analyses for each disease independently
using 31 EF cases and 19 CKCSID cases aligned to a common set
of 38 controls (unaffected for both conditions). Association
Authors Summary
The Cavalier King Charles Spaniel (CKCS) is popular as a
companion breed of dog in many countries worldwide.
However, in common with other breeds, it is documented
to suffer from a high frequency of inherited disorders,
which are largely the result of routine breeding practices.
The homogeneous population structure of individual
breeds is advantageous for mapping inherited conditions,
and we sought to utilise this by mapping two disorders,
episodic falling (EF) and congenital keratoconjunctivitis
sicca and ichthyosiform dermatosis (CKCSID), using a
genome-wide association study approach comprising a
set of cases for each condition and a single set of common
controls. Independent disease-associated regions were
identified for EF and CKCSID, both containing approxi-
mately 100 genes. In the absence of any provocative
candidate genes, we resequenced both entire regions
simultaneously using two cases for each disease and one
clinically unaffected control. A 15.7 kb deletion in the
BCAN gene was associated with EF and a 1 bp deletion in
FAM83H was associated with CKCSID. Neither gene has
been associated with similar conditions previously. This
investigation highlights how multiple disease-associated
mutations can be simultaneously identified in the dog with
a minimal set of individuals.
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chromosome 7 (Praw 1.9610
214 ;P genome=1.0610
25) and for
CKCSID on chromosome 13 (Praw 1.2610
217 ;P genome=
1.0610
25 ) (Figure 1). Genomic inflation values based on the
median chi-squared were 1.57 and 1.62 for the EF and CKCSID
association analyses respectively. This level of inflation of test
statistics is commonly observed in within-breed GWAS in the
purebred dog due to population substructure and high levels of
relatedness among individuals. We therefore conducted additional
association analyses to attempt to adjust for these effects using a
mixed model approach implemented in the statistical package R
[30]. The two top association signals remained statistically
associated at 4.1610
210 and 1.5610
211 for the EF and CKCSID
respectively. QQ plots are displayed for the corrected data in
Figure S1.
To identify regions of shared homozygosity between EF and
CKCSID cases, we visually examined individual SNP genotypes
spanning the two disease-associated regions. The positions of
recombination events in cases, resulting in loss of shared
homozygosity, were used to define the disease-associated critical
haplotype for EF (chromosome 7: 44,093,554 bp to 47,048,914
bp) and for CKCSID (chromosome 13: 39,648,169 bp to
42,481,707 bp) based on the CanFam2.0 reference genome. Genes
in the disease-associated regions and synteny to the human
chromosomes are displayed in Figures S2 and S3. There were six
EF cases that were not homozygous for the chromosome 7 disease-
associated haplotype. Of these six cases, five were owner reported
cases. The remaining discordant case had been diagnosed with EF
by a veterinary neurologist, but during a subsequent consultation
the dog was re-assessed and its diagnosis was changed to one of
primaryepilepsy.AllCKCSIDcaseswerehomozygousforthesame
disease-associated haplotype.
To attempt to identify the causal variants underlying the
association signals for each disease, we used a targeted resequen-
cing approach to resequence both the EF and the CKCSID
critical intervals of association in two EF cases, two CKCSID
Figure 1. Results of genome-wide association studies. For (A) EF and (B) CKCSID.
doi:10.1371/journal.pgen.1002462.g001
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based on specific haplotypes. Combined, the disease-associated
critical intervals spanned genomic regions totalling 5,788,898 bp.
Sequencing coverage was limited to approximately 65% of the
target regions, as repetitive DNA elements accounting for ,35%
of the target regions were masked during target enrichment probe
design. Sequence reads were aligned to the canine reference
genome, and SNP and indel calls were made and collated into a
single file. The aligned sequence reads were analysed for structural
variants by visual inspection and read depth comparison. We
identified ,8700 SNPs and ,1400 indels across the targeted
region per dog sequenced, in comparison to the canine reference
genome. We also identified deletions of ,6 kb, ,10 kb and
,16 kb, only the latter of which spanned a coding region. In the
EF disease-associated region, two provocative mutations were
identified that segregated with EF in the five dogs sequenced.
These were a single base mutation in the DENN/MADD domain
containing 4B gene (DENND4B) causing an arginine to a histidine
amino acid substitution, and a ,16 kb deletion encompassing the
first three exons of the brevican gene (BCAN) (Figure 2). Both
polymorphisms were further investigated by genotyping the full
panel of cases and controls used in the GWAS. The DENND4B
mutation did not segregate as strongly with EF as the BCAN
deletion and was thus excluded. In addition, the DENND4B
mutation was identified in three non-CKCS dogs (two Italian
Spinoni and one Golden Retriever) genotyped on the CanineHD
chip as array controls, so is likely to be a common canine
polymorphism. Full segregation analysis data is shown in Table
S1. Exact deletion breakpoints of the BCAN deletion were defined
by de novo assembly of the reads aligned across and surrounding the
deletion breakpoints using Gap4 (Staden Package) [31]. De novo
assembly revealed the deletion to be 15,724 bp with a small
insertion of 5 bp spanning the deletion breakpoints that is not
present in control dogs (Figure 3). In the CKCSID disease-
associated genomic region only a single provocative mutation was
identified that segregated appropriately with CKCSID in the five
dogs that were sequenced. This was a single base deletion in exon
5 of the gene family with sequence similarity 83, member H (FAM83H)
(Figure 4). Buccal epithelia and brain (cerebellum) cDNA
sequencing confirmed the exon boundaries of the FAM83H and
BCAN genes respectively (Genbank accession numbers JN968466–
JN968467). The BCAN deletion spans exons 1–3 and is potentially
a complete gene knockout. The FAM83H single base deletion is in
exon 5, and is predicted to truncate the peptide from 1151 to 582
amino acids, with 257 aberrant amino acids at the C terminal.
Quantitative reverse transcription PCR (qRT-PCR) was used to
assess FAM83H and BCAN expression levels in canine skin and
brain (cerebellum) tissues. BCAN expression was confirmed in the
brain, but was not detected in the skin. A similar level of FAM83H
expression was detected in both skin and brain (Figure 5).
FAM83H expression was also detected in footpad and buccal
epithelia by RT-PCR (data not shown).
To further validate the associations between the BCAN and
FAM83H deletions and EF and CKCSID respectively, we
genotyped a panel of 308 CKCS for both variants. This panel
included the 31 EF cases, 19 CKCSID cases and 38 controls used
in the GWAS analyses, and an additional 17 EF cases, 5 CKCSID
cases and 198 controls. Results are shown in Table 1. In addition a
panel of 341 dogs from 34 other breeds (with at least 2 dogs per
breed) were assayed for both the FAM83H and BCAN mutations.
All 341 dogs were homozygous wild-type for both polymorphisms.
From the panel of 308 CKCS genotyped for the BCAN or
FAM83H mutations, individuals that were not clinically affected,
unrelated at the parent level and not related to cases at the parent
level were used to estimate the mutation frequencies in the UK.
From these 122 individuals, the allele frequency of both variants
was estimated at 0.08.
Discussion
Using a genome-wide association study approach followed by
targeted resequencing, we have identified mutations in BCAN and
FAM83H associated with two genetically distinct autosomal
recessive conditions in the CKCS. We capitalised on the fact that
both diseases occurred in a single breed of dog, by using a single
set of common controls aligned to both case sets for the EF and
CKCSID association studies, and by using just five dogs to
resequence both disease-associated critical regions simultaneously.
This allowed the investigation to take place with a modest sample
set, and proved to be a highly efficient and effective method to
Figure 2. Sequence read alignments for an EF case, spanning the 59 region of the BCAN gene. Grey bars represent correctly aligned
sequence reads. Reads with a red perimeter indicate that the mate has not been aligned for the read pair. Blue bars represent reads that have been
flagged for inconsistent insert size; indicative of a genomic deletion.
doi:10.1371/journal.pgen.1002462.g002
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CKCS. The fact that we were able to use resequenced EF cases as
additional controls for CKCSID and vice-versa enabled us to
effectively filter sequence variants to limit the number of candidate
causal variants for follow-up.
No mutant BCAN or FAM83H alleles were detected among 341
dogs from 34 other breeds. This suggests that the two mutations
are limited to the CKCS breed, although only a small selection of
dogs was tested from just a subset of all dog breed populations.
Additional dogs would need to be screened to formally conclude
that the mutation is not present in any other breeds.
The EF-associated gene BCAN encodes brevican, which is one
of the central nervous system specific members of the hyaluronan-
binding chondroitin sulfate proteoglycan family [32]. Brevican is
important in the organisation of the nodes of Ranvier in
myelinated large diameter axons [33] and disruption of this
region results in a delay in axonal conduction [34]. Interestingly
the gene HAPLN2 is tandomly arranged upstream of BCAN.
HAPLN2 encodes Bral1, a brain specific hyaluronan and
protoglycan link protein and is co-localised with brevican and
versican V2 to form complexes at the nodes of Ranvier [34]. The
BCAN deletion moves the 39 UTR of HAPLN2 to within 2 kb of
exon 4 of BCAN. Expression analysis would be required to fully
establish whether the ,16 kb deletion causes a complete knock-
out of the BCAN gene and to investigate any potential effects on
HAPLN2 expression.
Mutations in BCAN have not previously been associated with a
disease phenotype and brevican-deficient mice are viable, fertile,
physiologically normal, display normal behaviour and have a
normal life expectancy [35]. However, the absence of any
apparent abnormalities in brevican-deficient mice may relate to
an absence of episode triggers within the environment the mice
were maintained in. In dogs, episodes are induced by exercise or
excitement and it is highly likely that mice will not exercise
sufficiently intensely within their routine laboratory environment.
EF has a variable phenotype in the CKCS and 17 out of 56 dogs
that were homozygous for the BCAN deletion were reportedly not
affected by EF, which suggests that the disorder may be influenced
by variation in environmental stimuli and potential variants in
modifier genes. As EF is an exercise-induced condition, differences
in levels of activity among affected dogs may partially account for
some of the phenotypic variation. One dog in our study that was
Figure 3. De novo assembly of reads, from a single EF case, aligned across the deletion.
doi:10.1371/journal.pgen.1002462.g003
Figure 4. IGV display of the 1 bp deletion in exon 5 of FAM83H.
doi:10.1371/journal.pgen.1002462.g004
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signs consistent with EF was reported by its owner to be ‘‘docile
and unexcitable’’, suggesting, for this dog at least, insufficient
environmental stimuli were provided to trigger the condition. In
addition, nine out of 48 EF cases were not homozygous for the
BCAN mutation. An extensive neurological assessment would be
required to mitigate against misclassification of these cases, but this
is often not possible for canine patients due to expense or lack of
owner consent. The CKCS breed is also affected by idiopathic
epilepsy, and the EF episodes may often be difficult to distinguish
from epileptic seizures, as a definitive diagnostic test is not
available for either condition [36]. It is therefore possible that for
some cases epilepsy or other neurological conditions have wrongly
been diagnosed as EF, although it is formally possible that there
may be a second, genetically distinct form of EF in the CKCS. We
did not completely resequence the entire association interval due
to the repetitive nature of around 35% of the sequence, and
although unsequenced regions were largely non-coding, potential
causal mutations could be situated within these regions and would
not therefore have been identified in our current study.
EF is a condition that becomes self-limiting and can self-rectify in
some cases, with some dogs becoming clinically normal after a
period of months to years of being clinically affected. It is interesting
to speculate that this might be due to compensatory effects of other
chondroitin sulphate proteoglycans in the brain, in particular
versican V2[33] taking overtherole of brevican, although the effect
could also be due to modified owner and/or dog behaviour in
response to the episodes, such as a change in exercise levels or the
avoidance of trigger events once these have been identified.
An identical mutation in BCAN has recently been associated
with EF in the CKCS, by an independent research group, and the
finding published whilst this manuscript was under review [37].
Several mutations in the CKCSID-associated gene FAM83H
have been associated with autosomal-dominant hypocalcification
amelogenesis imperfecta (ADHAI) in humans, which is a disease of
faulty tooth enamel formation [38]. To date the mutations
associated with ADHAI have all been found in exon 5 of FAM83H
and are either nonsense or frameshift mutations leading to a
premature stop codon after a sequence of aberrant amino acids.
Further to this, mutations in the 59 region of exon 5 appear to
result in a generalised phenotype, affecting all teeth, compared to
mutations occurring in the 39 region, which appear to give a
localised phenotype, with just a subset of teeth being affected [39].
The canine mutation is in a position which would predict a more
generalised phenotype. Anecdotal evidence suggests that CKCSID
cases do show clinical signs of tooth disease, although this is a post-
hoc observation and would require further investigation to
determine the exact nature of the dental problems.
The CKCSID phenotype suggests that FAM83H has an
important role in skin development and regulation, in addition
to enamel formation, at least in the dog. Limited expression
analysis has revealed that FAM83H is expressed in canine skin, and
also in the brain (cerebellum), footpad and buccal epithelia, in
concordance with previous reports that FAM83H may be
ubiquitously expressed [38]. Species-specific differences in gene
expression and function have not currently been investigated and
no significant skin or nail phenotypes have been associated with
ADHAI in human patients. In humans all FAM83H mutations
reported to date have been dominant, and no human patients with
homozygous FAM83H mutations have been reported. In contrast
the canine mutation is recessive and heterozygous dogs do not
have a discernable phenotype, so it is interesting to speculate that
the gene is playing a different role in enamel formation between
the two species and that human patients may present additional
Figure 5. Expression levels of BCAN and FAM83H. Expression levels in brain (B) and skin (S) relative to the reference gene ACTB. PCRs were
assessed at end point by agarose gel electrophoresis (A) and in real-time by qRT-PCR (B). Reactions performed in triplicate, but displayed as single
curves for illustrative purposes.
doi:10.1371/journal.pgen.1002462.g005
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FAM83H mutation was identified.
In summary, we have identified mutations in two genes that are
associated with distinct autosomal recessive disorders in the
CKCS, neither of which have been previously associated with
similar disease phenotypes in other species. The discovery of these
mutations may suggest potential novel biological functions for
FAM83H and BCAN, although formal proof of this would require
further functional data to confirm the causality of the two
mutations with respect to their associated disease phenotypes. This
study illustrates how two disease phenotypes in a single dog breed
can be investigated using a very modest sample set to successfully
identify disease-associated mutations, using a GWAS approach
followed by targeted resequencing.
Materials and Methods
Sample collection
All DNA samples were collected from CKCS in the general pet
dog population. We collected residual blood samples that were
drawn as part of a veterinary procedure or buccal swab samples
that were collected by owners or by veterinarians. EF cases were
defined as dogs reported by their owner and/or veterinarian to be
displaying clinical signs consistent with EF, based on descriptions
available in the scientific literature and in consultation with a
veterinary neurologist. Video evidence was used where possible. In
addition full neurological assessments were performed for some
cases to rule out any other underlying causes. There is no
definitive method of diagnosing EF, so diagnosis is based on the
identification of a consistent clinical phenotype with the exclusion
of other potential causes. All CKCSID cases included in the study
were assessed by a single veterinary ophthalmologist. The
additional panel of 341 dogs from 34 other breeds genotyped for
both the FAM83H and BCAN mutations were all reported by their
owners to be healthy and had been recruited to participate in
other unrelated studies.
DNA preparation
Genomic DNA was extracted from whole blood samples
preserved in EDTA using the Nucleon BACC2 kit (Tepnel Life
Science), or from buccal swabs using the QiaAmp Midi kit
(Qiagen). Samples were concentrated using 0.5 ml Amicon Ultra
100 K centrifugal filter columns (Millipore) and normalised to
50 ng/ml after quantification on a Qubit fluorometer (Invitrogen).
SNP genotyping and GWAS analyses
DNA samples from 31 EF cases, 19 CKCSID cases and 38
controls were genotyped using the Illumina CanineHD SNP
genotyping array that comprises 173,662 SNPs (single nucleotide
polymorphisms). The SNP genotyping dataset was analysed for
association using the statistical package PLINK [40]. Sample call
rates for all individuals were .99%. SNPs with a genotyping call
rate of ,95% and/or minor allele frequency of ,5% were
discarded. The strongest statistical signal from the unadjusted
association analysis is termed Praw (Figure 1). For the EF GWAS
91,427 SNPs were available for analysis following these quality
control filters and for CKCSID 88,384 SNPs remained for
analysis. Correction for multiple testing was performed using
100,000 MaxT permutations in PLINK. The strongest statistical
signal after permutation is termed Pgenome (Figure 1). Correction
for population substructure and relatedness was performed using a
mixed model, implemented in the statistical package R, and the
strongest statistical signal is termed Pcorrected (Figure 1) [30].
Sequencing
Libraries were created for sequencing using next generation
technology including the SureSelect solution based target
enrichment stage (Agilent Technologies). RNA bait probes
(120 bp) were designed to give 26 probe coverage of target
regions using the online tool e-array (https://earray.chem.agilent.
com/earray/). The total number of baits designed was 57,667
across 3.75 Mb of the 5.79 Mb target region (64.8% region
coverage). The remaining 35.2% consisted of repeat regions
that were masked during the bait design, or uncharacterised
regions of the reference genome, and were thus not captured or
resequenced.
Genomic DNA (5 mg) from two EF cases, two CKCSID cases
and one control dog was used to prepare libraries for sequencing.
DNA was fragmented by digesting with dsDNA Fragmentase
(New England Biolabs) for 23 minutes at 37uC. Library fragments
were end repaired, A-tailed and ligated to DNA adaptors for
paired-end multiplexed sequencing (Illumina) using the NEBNext
DNA Sample Prep Master Mix Set 1 (New England Biolabs).
Oligonucleotides for adaptors and library amplification were
manufactured by Integrated DNA Technologies. Pre-capture
library amplification, sequence capture, and post-capture ampli-
fication was conducted using the SureSelect target enrichment
system for Illumina paired-end multiplexed sequencing (Agilent
Technologies). Libraries were quantified using the KAPA Library
Quantification Kit (Kapa Biosystems). Paired-end sequencing
(51 bp reads) was carried out on a single lane of an Illumina GAIIx
at the Wellcome Trust Centre for Human Genetics, University of
Oxford, UK. A 3.47 Gb dataset was produced giving an average
read depth across target regions ranging from 95 to 114 for the five
DNA libraries.
Sequencing data analysis
Reads were aligned to the canine reference genome (Can-
Fam2.0) using BWA [41]. SNP and indel calls were made using
GATK [42]. Structural variant analysis was performed using
Pindel [43]. Aligned reads were viewed using The Integrative
Genomics Viewer (IGV) [44]. Polymorphisms occurring in exonic
regions causing non-synonymous changes and in splice donor or
acceptor sites were considered as candidate mutations. Candidate
mutations were considered potentially as causal if they were
homozygous mutant in cases and either heterozygous or
homozygous wild-type in controls.
Table 1. Summary of genotyping results on the panel of 308
dogs assayed for the BCAN ,16 kb deletion and the FAM83H
1 bp deletions.
BCAN Genotype
(2/2)( 2/wt) (wt/wt)
EF cases 39 3 6
EF controls 17 62 181
FAM83H Genotype
(2/2)( 2/wt) (wt/wt)
CKCSID cases 24 0 0
CKCSID controls 0 38 246
Homozygous mutants are shown in column (2/2), heterozygous dogs in
column (2/wt) and homozygous wild type dogs in column (wt/wt).
doi:10.1371/journal.pgen.1002462.t001
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RNA was extracted from post-mortem brain (cerebellum), skin
and footpad tissues preserved in RNAlater (Life Technologies) and
buccal epithelial tissue using a Qiagen RNeasy mini kit (Qiagen).
cDNA was prepared using a Qiagen Quantitect reverse transcrip-
tion kit. PCR was performed to confirm BCAN and FAM83H
transcripts using 12 ml reactions consisting of 0.2 mM dNTPs
(NEB), 16PCR buffer (Qiagen), 0.5 mM forward primer, 0.5 mM
reverse primer, 0.5 units HotStarTaq plus DNA polymerase
(Qiagen) and ultrapure water. For PCR of GC-rich (.70%)
regions, Q solution (Qiagen) was also added to the reaction at a
final 16 concentration. Cycling parameters for PCR were 95uC
for 10 minutes, followed by 35 cycles of 95uC for 30 seconds,
58uC for 30 seconds and 72uC for 60 seconds, and completed with
a final elongation stage of 72uC for 10 minutes. PCR products
were Sanger sequenced using Big Dye v3.1 (Applied Biosystems)
for capillary electrophoresis on an ABI3130xl genetic analyser.
Sequencing data were analysed using Gap4 (Staden package) [31].
Primers for cDNA sequencing are listed in Table S2. All primers
were designed using Primer3 [45] and manufactured by IDT.
qPCR assays were carried out on an Illumina Eco machine in
10 ml reactions containing 5 ml Kapa Probe Fast qPCR master-
mix, 16IDT PrimeTime qPCR assay mix and 2 ml cDNA (primer
sequences listed in Table S3). Reaction efficiencies were calculated
using a seven point 26serial dilution to create a standard curve.
BCAN, FAM83H and ACTB reaction efficiencies were estimated at
97.5%, 95.7% and 94.3% respectively, with standard curve r
2
values all .0.99.
Genotyping of FAM83H and BCAN deletions
The 15,724 bp BCAN deletion and 1 bp deletion in FAM83H
were assayed using PCR with fluorescently tagged primers. Primer
sequences are listed in Table S4. The assay for the BCAN deletion
used a three primer system and comprised a single fluorescently
labelled forward primer 59 of the deletion, paired with a reverse
primer in the deleted region and a reverse primer 39 of the deletion
(Table S3). The FAM83H 1 bp deletion was assayed using a single
primer pair, with the forward primer fluorescently labelled (Table
S3). Assays were performed in multiplex PCR consisting of 16
PCR buffer, 16Q solution, 200 mM dNTPs, 0.12 U Hotstar Taq
plus, 0.3 mM CKCSID_F and CKCSID_R, 0.14 mM EF_F,
0.09 mM EF_bridge_R, 0.24 mM EF_normal_R and ultrapure
water to a final volume of 12 ml. PCR cycling parameters were
95uC for 5 minutes, followed by 32 cycles of 95uC for 30 seconds,
58uC for 30 seconds and 72uC for 30 seconds, with a final
elongation stage of 72uC for 10 minutes. PCR products were
separated by capillary electrophoresis on ABI3130xl genetic
analysers. Genotyping data were analysed using GeneMapper
v4.0 (Applied Biosystems)
Ethics statement
Collection of blood samples solely for research purposes is
strictly monitored in the UK and requires a home office license.
However any residual blood remaining after being drawn as part
of a veterinary procedure may be used for research and does not
require a license. Buccal swabbing is a relatively non-invasive
procedure and does not require a license.
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Figure S1 QQ plots of Fast Mixed Model corrected allelic
association data for (A) EF and (B) CKCSID.
(TIF)
Figure S2 Graphical representation of genes in the EF disease
associated genomic region and the syntenic region of the human
genome, adapted from the Ensembl genome browser.
(TIF)
Figure S3 Graphical representation of genes in the CKCSID
disease associated genomic region and syntenic regions of the
human genome, adapted from the Ensembl genome browser.
(TIF)
Table S1 Genotype table for the FAM83H deletion (mutant
allele designated 76), BCAN deletion (mutant allele designated
112) and DENND4B SNP. DNAs listed are the 96 samples that
were genotyped in a single batch on the CanineHD SNP array,
including the 31 EF cases, 19 CKCSIS cases, and 38 controls.
Samples IDs marked * were excluded from the allelic association
analysis. Sample IDs 2275, 5404 (Italian Spinoni) and 4748
(Golden Retriever) were genotyped for control purposes. Samples
IDs 6804, 6836, 6888 and 15375 were CKCS ichthyosis cases.
Sample ID 16837 was a genotyping outlier and therefore
removed.
(DOC)
Table S2 Primers used for cDNA sequencing of the FAM83H
and BCAN genes.
(DOC)
Table S3 Primers used for qPCR assays of the BCAN, FAM83H
and ACTB (control) genes. All probes were 59 6-FAM and 39 Iowa
Black labelled, with internal ZEN labelling.
(DOC)
Table S4 Primers used in the genotyping assay for the BCAN
and FAM83H mutations. The expected mutant product size for
the CKCSID primer pair refers to the 1 bp deletion in the
FAM83H gene and for the EF primer pairs refers to the 15,724 bp
deletion encompassing the first three exons of BCAN.
(DOC)
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